1620278-39-8: 3-Deamino 3-Hydroxy Linagliptin

3-Deamino 3-Hydroxy Linagliptin (CAS No: 1620278-39-8) Or (S)-7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, It is an impurity of Linagliptin, Linagliptin is a competitive, reversible inhibitor of DPP-4, which is an enzyme that degrades the incretin hormones glucagon-like peptide-1, is used to decreased glycosylated hemoglobin and fasting plasma glucose.

Additional information on CAS 1620278-39-8

Catalogue No.

VE009587

CAS No.

1620278-39-8

Molecular Formula

C25H27N7O3

Molecular Weight

473.53 g/mol

Parent drug

Linagliptin

IUPAC Name

(S)-7-(but-2-yn-1-yl)-8-(3-hydroxypiperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2, 6(3H, 7H)-dione

Synonyms

N/A

References

Freeman, M. K. (2011). Efficacy and safety of linagliptin (tradjenta) in adults with type-2 diabetes mellitus. P & T : A Peer-Reviewed Journal for Formulary Management, 36(12), 807–842. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278179/

Status

In-stock